1191911-27-9 Usage
Description
CZC-54252 is a pharmaceutical compound that functions as an inhibitor of leucine-rich repeat kinase 2 (LRRK2). This enzyme plays a significant role in the development of familial Parkinson's disease, making it a potential therapeutic target for treatment.
Uses
Used in Pharmaceutical Industry:
CZC-54252 is used as an inhibitor for leucine-rich repeat kinase 2 (LRRK2) due to its association with familial Parkinson's disease. By inhibiting LRRK2, it may help in the development of therapeutic strategies to manage or treat this neurodegenerative condition.
Check Digit Verification of cas no
The CAS Registry Mumber 1191911-27-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,1,9,1 and 1 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1191911-27:
(9*1)+(8*1)+(7*9)+(6*1)+(5*9)+(4*1)+(3*1)+(2*2)+(1*7)=149
149 % 10 = 9
So 1191911-27-9 is a valid CAS Registry Number.
1191911-27-9Relevant articles and documents
N2,N4-DIPHENYLPYRIMIDINE-2,4-DIAMINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER
-
Paragraph 0185; 0190, (2020/05/07)
The present invention relates to a N2,N4-diphenylpyrimidin-2,4-diamine derivative, a method for preparing the same, and a pharmaceutical composition for the prevention or treatment of cancer, containing the same as an active ingredient. The derivative sho